All right, it’s not quite that simple. But the dramatic fall of TorreyPines Therapeutics does have something to do with the … well, previously up-and-coming migraine drug, Tezampanel. It happened back in 2007. TorreyPines had been working on a new kind of drug for migraine, and had been hoping to expand it to other types [...]
by James on 12 March 2009
Trials for the new migraine drug, Tezampanel (NGX424), are moving quickly ahead. So it’s time to catch up on what this drug is, and who it might help. Tezampanel is based on an emerging understanding of the role of glutamate (an amino acid) in pain. Targeting glutamate receptors (either through antagonists like Tezampanel or through [...]